| Futrell Counseling & Consulting Llc | |
|
955 Forest St Dover DE 19904-3401 | |
| (302) 760-9736 | |
| (302) 329-3107 |
| Full Name | Futrell Counseling & Consulting Llc |
|---|---|
| Speciality | Social Worker |
| Location | 955 Forest St, Dover, Delaware |
| Authorized Official Name and Position | Mamie Futrell (MANAGING MEMBER) |
| Authorized Official Contact | 4845429883 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Futrell Counseling & Consulting Llc 217 Buckeye Ln Smyrna DE 19977-5246 Ph: () - | Futrell Counseling & Consulting Llc 955 Forest St Dover DE 19904-3401 Ph: (302) 760-9736 |
| NPI Number | 1659045433 |
|---|---|
| Provider Enumeration Date | 08/04/2021 |
| Last Update Date | 02/26/2023 |
| Certification Date | 02/26/2023 |
| Medicare PECOS PAC ID | 9830596949 |
|---|---|
| Medicare Enrollment ID | O20210916000296 |
News Archive
In this post in the Center for Global Development's "Global Health Policy" blog, William Savedoff, a senior fellow at the center, responds to a high level panel's assessment (.pdf) of fiduciary controls at the Global Fund to Fight, AIDS, Tuberculosis and Malaria, examining "what this report might mean for an organization that was expressly created to blaze an innovative approach to international aid and is being counseled to back away from that vision."
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released its second annual study on the state of the U.S. Food and Drug Administration (FDA) drug review process.
New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659045433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Mamie Futrell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1144994161 PECOS PAC ID: 0749687853 Enrollment ID: I20210916000461 |
News Archive
In this post in the Center for Global Development's "Global Health Policy" blog, William Savedoff, a senior fellow at the center, responds to a high level panel's assessment (.pdf) of fiduciary controls at the Global Fund to Fight, AIDS, Tuberculosis and Malaria, examining "what this report might mean for an organization that was expressly created to blaze an innovative approach to international aid and is being counseled to back away from that vision."
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released its second annual study on the state of the U.S. Food and Drug Administration (FDA) drug review process.
New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.
› Verified 5 days ago
| Provider Name | Breanna Pelleschi |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1295132181 PECOS PAC ID: 0648512640 Enrollment ID: I20230117000123 |
News Archive
In this post in the Center for Global Development's "Global Health Policy" blog, William Savedoff, a senior fellow at the center, responds to a high level panel's assessment (.pdf) of fiduciary controls at the Global Fund to Fight, AIDS, Tuberculosis and Malaria, examining "what this report might mean for an organization that was expressly created to blaze an innovative approach to international aid and is being counseled to back away from that vision."
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released its second annual study on the state of the U.S. Food and Drug Administration (FDA) drug review process.
New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.
› Verified 5 days ago
| Provider Name | Summer Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1588375323 PECOS PAC ID: 5496120636 Enrollment ID: I20230331001022 |
News Archive
In this post in the Center for Global Development's "Global Health Policy" blog, William Savedoff, a senior fellow at the center, responds to a high level panel's assessment (.pdf) of fiduciary controls at the Global Fund to Fight, AIDS, Tuberculosis and Malaria, examining "what this report might mean for an organization that was expressly created to blaze an innovative approach to international aid and is being counseled to back away from that vision."
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released its second annual study on the state of the U.S. Food and Drug Administration (FDA) drug review process.
New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.
› Verified 5 days ago
News Archive
In this post in the Center for Global Development's "Global Health Policy" blog, William Savedoff, a senior fellow at the center, responds to a high level panel's assessment (.pdf) of fiduciary controls at the Global Fund to Fight, AIDS, Tuberculosis and Malaria, examining "what this report might mean for an organization that was expressly created to blaze an innovative approach to international aid and is being counseled to back away from that vision."
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released its second annual study on the state of the U.S. Food and Drug Administration (FDA) drug review process.
New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.
› Verified 5 days ago
Northnode Group Counseling Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1609 S State St, Dover, DE 19901 Phone: 302-257-3135 Fax: 302-526-2410 | |
I & K Quality Health Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 229 Jordan Dr, Dover, DE 19904 Phone: 303-674-5259 | |
Goodnights Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 725 Walker Rd, Dover, DE 19904 Phone: 302-270-3906 | |
Indigo Wellness, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 144 Kings Hwy Ste 302, Dover, DE 19901 Phone: 302-450-3936 Fax: 302-450-3927 | |
Kent Sussex Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1241 College Park Dr, Dover, DE 19904 Phone: 302-735-7790 Fax: 302-735-3654 | |
Embracing Oak Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9 E Loockerman St Ste 302, Dover, DE 19901 Phone: 412-953-2791 | |
A Center For Mental Wellness Community Support Programs, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 W Loockerman St, Dover, DE 19904 Phone: 302-674-1397 Fax: 302-674-1602 |